691900-59-1

Usage

Uses

Used in Pharmaceutical Industry:
6-Methoxy-1H-indazole-3-carbonitrile is used as an intermediate in the synthesis of pharmaceutical drugs for its ability to contribute to the development of indazolium dyes and other pharmaceuticals. Its presence in the manufacturing process allows for the creation of a diverse range of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 6-Methoxy-1H-indazole-3-carbonitrile is utilized in the production of pesticides, herbicides, and other agricultural products. Its role in these applications is to enhance the effectiveness of these products, contributing to improved crop protection and yield.
Overall, 6-Methoxy-1H-indazole-3-carbonitrile is a vital component in the synthesis and production processes across different industries, highlighting its importance in the development of various organic compounds for both medicinal and agricultural purposes.

Upstream product

• 17484-36-5 4-Methyl-3-nitroanisole 
• 57559-52-1 4-methoxy-2-nitrobenzyl bromide 
• 105003-90-5 (4-methoxy-2-nitro-phenyl)-acetonitrile 
• 65547-98-0 ethyl 2-cyano-2-(4-methoxy-2-nitrophenyl)acetate 
• 10298-80-3 2-chloro-5-methoxynitrobenzene 
• 118671-03-7 2-(2-amino-4-methoxyphenyl)acetonitrile 

Downstream Products

• 1236352-57-0 (4-bromophenyl)(6-methoxy-1H-indazol-3-yl)methanone 
• 1236352-58-1 1-{3-[(4-bromophenyl)carbonyl]-6-methoxy-1H-indazol-1-yl}-3,3-dimethylbutan-2-one 
• 1236352-60-5 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1H-indazol-3-yl]carbonyl}(carboxy-14C)benzoic acid 
• 1236352-59-2 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1H-indazol-3-yl]-carbonyl}(formyl-14C)benzaldehyde 
• 691900-61-5 C₁₅H₁₂N₂O₂ 

Relevant academic research and scientific papers

ETHER COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION

This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relate

OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION

This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also rela

Ophthalmic compositions for treating ocular hypertension

This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relate